TickerFactsScreenerDevelopers

Kiniksa Pharmaceuticals International, plc (KNSA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$50.22M2018: -$81.01M2019: -$158.37M2020: -$136.53M2021: -$126.30M2022: $5.81M2023: $13.30M2024: $25.69M2025: $137.99M$137.99M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$137.99M+437.1%
2024$25.69M+93.1%
2023$13.30M+129.1%
2022$5.81M+104.6%
2021-$126.30M+7.5%
2020-$136.53M+13.8%
2019-$158.37M-95.5%
2018-$81.01M-61.3%
2017-$50.22M—